HKETO Newsroom

October 26, 2022

HKETO supports Canadian hybrid mission to join the ASGH 2022

Director of the Hong Kong Economic and Trade Office (Toronto) (HKETO), Ms Emily Mo, joined the “Canadian Hybrid Mission to Asia Summit on Global Health (ASGH)” pre-mission networking meeting jointly organised by HKETO, Hong Kong Trade Development Council (HKTDC), Invest Hong Kong (Canada) and the Hong Kong-Canada Business Association (HKCBA) on October 26.  

The pre-mission networking meeting aimed to provide Canadian delegates with an overview of the ASGH programme, and how they can take advantage of this trade mission to exchange insights, explore opportunities and collaborate with stakeholders from around the world through the Hong Kong platform. Themed “Charting a New Course in Healthcare through Collaboration”, this second Asia Summit on Global Health will be staged in Hong Kong from November 10 to 11.  

In delivering the opening remarks, Ms Mo was delighted to share with participants that Hong Kong has a vibrant ecosystem for start-ups, including those focusing on health-related areas.

“Our major technological infrastructures, the Hong Kong Science and Technology Park and Cyberport, have been supporting start-ups in healthcare, such as those applying AI in the field of virtual healthcare and big data,” Ms Mo said.  

She shared with participants that Hong Kong is now Asia’s largest and the world’s second-largest fundraising hub for biotech companies, and start-ups in Hong Kong increased significantly from 2017 to 2021 by almost 70% to over 3,700.

Apart from business, Hong Kong has established a solid foundation in research through world-class universities and technological infrastructure. “We have five universities among the world’s top 100, and among them two excellent medical schools.  Our collaboration with the Mainland China in this area is growing rapidly,” Ms Mo continued.  

Besides, Ms Mo highlighted Hong Kong has a robust Intellectual Property protection regime and about one third of the patents filings from local and overseas applications are in the fields of biotechnology, pharmaceuticals and media technology.

Before closing, Ms Mo encouraged participants to make use of the Hong Kong platform to connect and expand their businesses in Asia and the Mainland of China.

The networking meeting was chaired by Board Director of HKCBA (Ottawa Section) Ms Sandra Wu. Head of Investment Promotion of HKETO, Mr Christopher Chen, introduced the healthcare development and investment landscape in Hong Kong to participants, while the Marketing Manager of HKTDC, Ms Adrienne Ho, reviewed the ASGH program to facilitate the Canadian delegates in joining the Summit.  

October 26, 2022

香港經貿處支持加拿大代表團網上及實體參加2022亞洲醫療健康高峰論壇  

香港駐多倫多經濟貿易辦事處(香港經貿處)處長巫菀菁於十月二十六日參與由香港經貿處、香港貿易發展局(香港貿發局)、香港投資推廣署加拿大辦事處及港加商會合辦的「加拿大代表團網上及實體參加亞洲醫療健康高峰論壇」(健康高峰論壇)交流會。

該網上交流會旨在向加拿大代表團簡介健康高峰論壇的活動內容及如何透過這次貿易團善用香港平台與世界各地的持份者交流意見,以及探討商機和國際商貿合作的機會。第二屆題為「攜手合作  創新里程」的健康高峰論壇將於十一月十至十一日在香港舉行。

巫菀菁在交流會致歡迎辭時,首先向與會者介紹香港為初創企業提供的蓬勃生態圈,特別是與醫療健康產業有關的範疇。巫菀菁表示:「我們的主要創科基建 — 香港科技園及數碼港,一直支持醫療健康界別初創企業的發展,例如應用人工智能於網上健康服務及大數據等領域。」

巫菀菁表示,香港已成為亞洲最大及全球第二大生物科技公司的融資中心,香港整體的初創企業由2017年至2021年間大幅增加接近70%至逾3,700家。

除了商業方面,香港的世界一流學府及創科基礎設施亦鞏固了香港的科研基礎。巫菀菁續說:「香港擁有五間世界百強大學,其中兩所是優秀的醫學院。我們與中國內地在這方面的合作亦正迅速發展。」

此外,巫菀菁強調,香港擁有健全的知識產權保護制度,本地及海外提交的專利申請中,約有三分之一屬於生物科技、醫藥及媒體科技領域。

最後,巫菀菁鼓勵與會者善用香港平台,聯繫及發展業務至亞洲及中國內地。

交流會由港加商會(渥太華分會)董事Sandra Wu主持,香港經貿處投資推廣總監陳立智向與會者介紹香港的醫療保健發展和投資前景,而香港貿發局市務經理何洛怡則簡述健康高峰論壇的內容,以協助加拿大代表參加峰會。